Notably, the expression levels of RECK can predict the prognosis of various common cancers; lower RECK levels are often linked to increased invasiveness and a poorer prognosis (Takenaka et al., 2004; Kotzsch et al., 2005). This evidence concerns the gene RECK and cancer.